{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:13:03Z","timestamp":1790665983602,"version":"4.1.0"},"reference-count":165,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2018,10,23]]},"DOI":"10.3233\/jnd-180309","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T18:36:35Z","timestamp":1533062195000},"page":"387-406","source":"Crossref","is-referenced-by-count":50,"title":["Centronuclear myopathies under attack: A plethora of therapeutic targets"],"prefix":"10.1177","volume":"5","author":[{"given":"Hichem","family":"Tasfaout","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Neurogenetics, Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), Illkirch, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U1258, Illkirch, France"},{"name":"Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France"},{"name":"Universit\u00e9 de Strasbourg, Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda S.","family":"Cowling","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Neurogenetics, Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), Illkirch, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U1258, Illkirch, France"},{"name":"Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France"},{"name":"Universit\u00e9 de Strasbourg, Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Laporte","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Neurogenetics, Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), Illkirch, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U1258, Illkirch, France"},{"name":"Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France"},{"name":"Universit\u00e9 de Strasbourg, Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JND-180309_ref1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","article-title":"Centronuclear myopathies: A widening concept","volume":"20","author":"Romero","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-180309_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.1966.00470070005001","article-title":"Myotubular myopathy. Persistence of fetal muscle in an adolescent boy","volume":"14","author":"Spiro","year":"1966","journal-title":"Arch Neurol"},{"issue":"2","key":"10.3233\/JND-180309_ref3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat Genet"},{"key":"10.3233\/JND-180309_ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbior.2016.09.001","article-title":"WANTED - Dead or alive: Myotubularins, a large disease-associated protein family","volume":"63","author":"Raess","year":"2017","journal-title":"Adv Biol Regul"},{"key":"10.3233\/JND-180309_ref5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.3233\/JND-180309_ref6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J Pediatr"},{"issue":"13","key":"10.3233\/JND-180309_ref7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0000000000004415","article-title":"A natural history study of X-linked myotubular myopathy","volume":"89","author":"Amburgey","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-180309_ref8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.1033","article-title":"Diagnosis of X-linked myotubular myopathy by detection of myotubularin","volume":"50","author":"Laporte","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JND-180309_ref9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nmd.2010.03.015","article-title":"Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations","volume":"20","author":"Tosch","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"14","key":"10.3233\/JND-180309_ref10","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1074\/jbc.M312294200","article-title":"Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction","volume":"279","author":"Tsujita","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"10.3233\/JND-180309_ref11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1600-0854.2007.00586.x","article-title":"Myotubularin lipid phosphatase binds the hVPS15\/hVPS34 lipid kinase complex on endosomes","volume":"8","author":"Cao","year":"2007","journal-title":"Traffic"},{"issue":"7586","key":"10.3233\/JND-180309_ref12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nature16516","article-title":"A phosphoinositide conversion mechanism for exit from endosomes","volume":"529","author":"Ketel","year":"2016","journal-title":"Nature"},{"issue":"44","key":"10.3233\/JND-180309_ref13","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.1073\/pnas.0900705106","article-title":"T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase","volume":"106","author":"Al-Qusairi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.3233\/JND-180309_ref14","doi-asserted-by":"crossref","first-page":"e1000372","DOI":"10.1371\/journal.pgen.1000372","article-title":"Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy","volume":"5","author":"Dowling","year":"2009","journal-title":"PLoS Genet"},{"issue":"1","key":"10.3233\/JND-180309_ref15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI44021","article-title":"Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle","volume":"121","author":"Hnia","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.3233\/JND-180309_ref16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.3233\/JND-180309_ref17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1242\/dmm.009746","article-title":"Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"Dis Model Mech"},{"issue":"3","key":"10.3233\/JND-180309_ref18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajpath.2012.05.016","article-title":"Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment","volume":"181","author":"Lawlor","year":"2012","journal-title":"Am J Pathol"},{"issue":"6","key":"10.3233\/JND-180309_ref19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ajpath.2014.03.003","article-title":"Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 R69C mice","volume":"184","author":"Lawlor","year":"2014","journal-title":"Am J Pathol"},{"issue":"4","key":"10.3233\/JND-180309_ref20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/brb3.147","article-title":"Extensive morphological and immunohistochemical characterization in myotubular myopathy","volume":"3","author":"Shichiji","year":"2013","journal-title":"Brain Behav"},{"issue":"8","key":"10.3233\/JND-180309_ref21","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1096\/fj.12-220947","article-title":"Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways","volume":"27","author":"Al-Qusairi","year":"2013","journal-title":"FASEB J"},{"issue":"1","key":"10.3233\/JND-180309_ref22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/MCB.01075-12","article-title":"Defective autophagy and mTORC1 signaling in myotubularin null mice","volume":"33","author":"Fetalvero","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.3233\/JND-180309_ref23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00401-017-1748-0","article-title":"Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: Delineating diagnostic clues","volume":"134","author":"Biancalana","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.3233\/JND-180309_ref24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat Genet"},{"issue":"6","key":"10.3233\/JND-180309_ref25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/humu.22067","article-title":"Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy","volume":"33","author":"Bohm","year":"2012","journal-title":"Hum Mutat"},{"issue":"6","key":"10.3233\/JND-180309_ref26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ana.21235","article-title":"Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset","volume":"62","author":"Bitoun","year":"2007","journal-title":"Ann Neurol"},{"issue":"4","key":"10.3233\/JND-180309_ref27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nmd.2010.02.016","article-title":"Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy","volume":"20","author":"Susman","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.3233\/JND-180309_ref28","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1091\/mbc.8.12.2553","article-title":"Ubiquitously expressed dynamin-II has a higher intrinsic GTPase activity and a greater propensity for self-assembly than neuronal dynamin-I","volume":"8","author":"Warnock","year":"1997","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.3233\/JND-180309_ref29","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1091\/mbc.e02-09-0626","article-title":"Dynamin regulates focal exocytosis in phagocytosing macrophages","volume":"14","author":"Di","year":"2003","journal-title":"Mol Biol Cell"},{"issue":"10","key":"10.3233\/JND-180309_ref30","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.4049\/jimmunol.181.10.6995","article-title":"Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity","volume":"181","author":"Arneson","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.3233\/JND-180309_ref31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/bbrc.1996.0876","article-title":"Dynamin II binds to the trans-Golgi network","volume":"223","author":"Maier","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JND-180309_ref32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.279.5350.573","article-title":"Role of dynamin in the formation of transport vesicles from the trans-Golgi network","volume":"279","author":"Jones","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.3233\/JND-180309_ref33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/35000081","article-title":"Kinesin and dynamin are required for post-Golgi transport of a plasma-membrane protein","volume":"2","author":"Kreitzer","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"21","key":"10.3233\/JND-180309_ref34","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/emboj.2010.249","article-title":"Direct dynamin-actin interactions regulate the actin cytoskeleton","volume":"29","author":"Gu","year":"2010","journal-title":"Embo J"},{"issue":"1","key":"10.3233\/JND-180309_ref35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1083\/jcb.151.1.187","article-title":"Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape","volume":"151","author":"McNiven","year":"2000","journal-title":"J Cell Biol"},{"issue":"4","key":"10.3233\/JND-180309_ref36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncb1112","article-title":"Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion","volume":"6","author":"Thompson","year":"2004","journal-title":"Nat Cell Biol"},{"issue":"30","key":"10.3233\/JND-180309_ref37","doi-asserted-by":"crossref","first-page":"22753","DOI":"10.1074\/jbc.C110.130013","article-title":"Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"issue":"18","key":"10.3233\/JND-180309_ref38","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/emboj.2010.187","article-title":"Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients","volume":"29","author":"Kenniston","year":"2010","journal-title":"EMBO J"},{"issue":"5","key":"10.3233\/JND-180309_ref39","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ajpath.2011.01.054","article-title":"Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness","volume":"178","author":"Cowling","year":"2011","journal-title":"Am J Pathol"},{"issue":"8","key":"10.3233\/JND-180309_ref40","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1172\/JCI46267","article-title":"Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy","volume":"121","author":"Liu","year":"2011","journal-title":"J Clin Invest"},{"issue":"9","key":"10.3233\/JND-180309_ref41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","article-title":"Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy","volume":"39","author":"Nicot","year":"2007","journal-title":"Nat Genet"},{"issue":"6","key":"10.3233\/JND-180309_ref42","doi-asserted-by":"crossref","first-page":"e1003430","DOI":"10.1371\/journal.pgen.1003430","article-title":"Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy","volume":"9","author":"Bohm","year":"2013","journal-title":"PLoS Genet"},{"issue":"Pt 12","key":"10.3233\/JND-180309_ref43","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/brain\/awu272","article-title":"Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations","volume":"137","author":"Bohm","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JND-180309_ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-5-35","article-title":"Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation","volume":"5","author":"Bohm","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.3233\/JND-180309_ref45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.0b013e3181cef7f9","article-title":"Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation","volume":"74","author":"Claeys","year":"2010","journal-title":"Neurology"},{"issue":"5584","key":"10.3233\/JND-180309_ref46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1071362","article-title":"Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"issue":"22","key":"10.3233\/JND-180309_ref47","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1038\/sj.emboj.7600442","article-title":"Regulation of Bin1 SH3 domain binding by phosphoinositides","volume":"23","author":"Kojima","year":"2004","journal-title":"EMBO J"},{"issue":"18","key":"10.3233\/JND-180309_ref48","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1093\/emboj\/17.18.5273","article-title":"Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation","volume":"17","author":"Owen","year":"1998","journal-title":"Embo J"},{"issue":"10","key":"10.3233\/JND-180309_ref49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/embor.2013.119","article-title":"The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies","volume":"14","author":"Royer","year":"2013","journal-title":"EMBO Re"},{"issue":"6","key":"10.3233\/JND-180309_ref50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nm.2374","article-title":"Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy","volume":"17","author":"Fugier","year":"2011","journal-title":"Nat Med"},{"issue":"4","key":"10.3233\/JND-180309_ref51","doi-asserted-by":"crossref","first-page":"e1002595","DOI":"10.1371\/journal.pgen.1002595","article-title":"Defective membrane remodeling in neuromuscular diseases: Insights from animal models","volume":"8","author":"Cowling","year":"2012","journal-title":"PLoS Genet"},{"key":"10.3233\/JND-180309_ref52","doi-asserted-by":"crossref","unstructured":"Biancalana V , Beggs AH , Das S , Jungbluth H , Kress W , Nishino I , et al. Clinical utility gene card for: Centronuclear and myotubular myopathies. Eur J Hum Genet. 2012) 20(10).","DOI":"10.1038\/ejhg.2012.91"},{"issue":"5","key":"10.3233\/JND-180309_ref53","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.3233\/JND-180309_ref54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2990.2010.01149.x","article-title":"Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization","volume":"37","author":"Bevilacqua","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"14","key":"10.3233\/JND-180309_ref55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan-Birsoy","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-180309_ref56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","article-title":"SPEG Interacts with Myotubularin, and Its Deficiency Causes Centronuclear Myopathy with Dilated Cardiomyopathy","volume":"95","author":"Agrawal","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.3233\/JND-180309_ref57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-016-1656-8","article-title":"Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy","volume":"133","author":"Schartner","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"10.3233\/JND-180309_ref58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/brain\/aww257","article-title":"Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion","volume":"140","author":"Vasli","year":"2017","journal-title":"Brain"},{"issue":"21","key":"10.3233\/JND-180309_ref59","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","article-title":"A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy","volume":"15","author":"Tosch","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JND-180309_ref60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","article-title":"Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores","volume":"91","author":"Majczenko","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"23","key":"10.3233\/JND-180309_ref61","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1073\/pnas.212498399","article-title":"The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice","volume":"99","author":"Buj-Bello","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.3233\/JND-180309_ref62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-010-0754-2","article-title":"Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies","volume":"121","author":"Toussaint","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.3233\/JND-180309_ref63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41556-017-0024-9","article-title":"The MTM1-UBQLN2-HSPs complex mediate degradation of misfolded intermediate filaments in skeletal muscle","volume":"20","author":"Gavriilidis","year":"2018","journal-title":"Nature Cell Biol"},{"issue":"4","key":"10.3233\/JND-180309_ref64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddr512","article-title":"Modeling the human MTM1 R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype","volume":"21","author":"Pierson","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.3233\/JND-180309_ref65","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI86841","article-title":"PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models","volume":"126","author":"Sabha","year":"2016","journal-title":"J Clin Invest"},{"issue":"33","key":"10.3233\/JND-180309_ref66","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.1003677107","article-title":"MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers","volume":"107","author":"Beggs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.3233\/JND-180309_ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-014-0025-3","article-title":"X-linked myotubular myopathy in Rottweiler dogs is caused by a missense mutation in Exon 11 of the MTM1 gene","volume":"5","author":"Shelton","year":"2015","journal-title":"Skelet Muscle"},{"issue":"24","key":"10.3233\/JND-180309_ref68","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1093\/hmg\/ddq413","article-title":"A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice","volume":"19","author":"Durieux","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JND-180309_ref69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1600-0854.2012.01348.x","article-title":"A centronuclear myopathy\u2013dynamin 2 mutation impairs autophagy in mice","volume":"13","author":"Durieux","year":"2012","journal-title":"Traffic"},{"issue":"11","key":"10.3233\/JND-180309_ref70","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1242\/bio.020263","article-title":"Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy","volume":"5","author":"Fraysse","year":"2016","journal-title":"Biol Open"},{"issue":"24","key":"10.3233\/JND-180309_ref71","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1113\/JP274990","article-title":"Impaired excitation-contraction coupling in muscle fibres from the dynamin2(R465W) mouse model of centronuclear myopathy","volume":"595","author":"Kutchukian","year":"2017","journal-title":"J Physiol"},{"issue":"1","key":"10.3233\/JND-180309_ref72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1242\/dmm.012286","article-title":"The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish","volume":"7","author":"Gibbs","year":"2014","journal-title":"Dis Model Mech"},{"issue":"14","key":"10.3233\/JND-180309_ref73","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/hmg\/ddn112","article-title":"AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis","volume":"17","author":"Buj-Bello","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.3233\/JND-180309_ref74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"issue":"21","key":"10.3233\/JND-180309_ref75","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"issue":"25","key":"10.3233\/JND-180309_ref76","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.3233\/JND-180309_ref77","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson\u2019s disease: An open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.3233\/JND-180309_ref78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.3233\/JND-180309_ref79","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2011-3002","article-title":"Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients","volume":"97","author":"Carpentier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.3233\/JND-180309_ref80","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: An open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther"},{"issue":"220","key":"10.3233\/JND-180309_ref81","doi-asserted-by":"crossref","first-page":"220ra10","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy","volume":"6","author":"Childers","year":"2014","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.3233\/JND-180309_ref82","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/mus.25658","article-title":"Long-term effects of systemic gene therapy in a canine model of myotubular myopathy","volume":"56","author":"Elverman","year":"2017","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.3233\/JND-180309_ref83","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2017.02.004","article-title":"Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs","volume":"25","author":"Mack","year":"2017","journal-title":"Mol Ther"},{"issue":"4","key":"10.3233\/JND-180309_ref84","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/hum.2017.042","article-title":"Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines","volume":"28","author":"Kotin","year":"2017","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.3233\/JND-180309_ref85","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.3233\/JND-180309_ref86","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1074\/jbc.273.9.5288","article-title":"Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line","volume":"273","author":"Crawford","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.3233\/JND-180309_ref87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"issue":"19","key":"10.3233\/JND-180309_ref88","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197411072911901","article-title":"Replacement therapy for inherited enzyme deficiency Use of purified glucocerebrosidase in Gaucher\u2019s disease","volume":"291","author":"Brady","year":"1974","journal-title":"N Engl J Med"},{"issue":"9227","key":"10.3233\/JND-180309_ref89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.3233\/JND-180309_ref90","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"issue":"9","key":"10.3233\/JND-180309_ref91","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1038\/mtna.2016.67","article-title":"Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing","volume":"5","author":"Trochet","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10.3233\/JND-180309_ref92","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/wrna.1347","article-title":"mRNA trans-splicing in gene therapy for genetic diseases","volume":"7","author":"Berger","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"14","key":"10.3233\/JND-180309_ref93","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1093\/hmg\/ddv141","article-title":"Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3\u2019 splice sites","volume":"24","author":"Philippi","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JND-180309_ref94","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/mt.2014.35","article-title":"Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing","volume":"22","author":"Monjaret","year":"2014","journal-title":"Mol Ther"},{"issue":"22","key":"10.3233\/JND-180309_ref95","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.gt.3301307","article-title":"Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing","volume":"7","author":"Mansfield","year":"2000","journal-title":"Gene Ther"},{"issue":"17","key":"10.3233\/JND-180309_ref96","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/hmg\/ddp264","article-title":"Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing","volume":"18","author":"Rodriguez-Martin","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.3233\/JND-180309_ref97","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jid.2012.101","article-title":"Spliceosome-mediated trans-splicing: The therapeutic cut and paste","volume":"132","author":"Wally","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JND-180309_ref98","first-page":"2017","article-title":"Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy","author":"Trochet","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.3233\/JND-180309_ref99","doi-asserted-by":"crossref","first-page":"R285","DOI":"10.1093\/hmg\/ddg273","article-title":"Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases","volume":"12","author":"Laporte","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JND-180309_ref100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/bbrc.2002.6445","article-title":"Functional redundancy in the myotubularin family","volume":"291","author":"Laporte","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"10.3233\/JND-180309_ref101","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.171306098","article-title":"Characterization of an adapter subunit to a phosphatidylinositol (3)P 3- phosphatase: Identification of a myotubularin-related protein lacking catalytic activity","volume":"98","author":"Nandurkar","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.3233\/JND-180309_ref102","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/hmg\/11.13.1569","article-title":"Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1","volume":"11","author":"Berger","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JND-180309_ref103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/75542","article-title":"Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2","volume":"25","author":"Bolino","year":"2000","journal-title":"Nat Genet"},{"issue":"19","key":"10.3233\/JND-180309_ref104","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1093\/hmg\/ddx258","article-title":"Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy","volume":"26","author":"Raess","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1-2","key":"10.3233\/JND-180309_ref105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(01)00876-9","article-title":"Molecular characterization and expression analysis of Mtmr2, mouse homologue of MTMR2, the Myotubularin-related 2 gene, mutated in CMT4B","volume":"283","author":"Bolino","year":"2002","journal-title":"Gene"},{"issue":"4","key":"10.3233\/JND-180309_ref106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/nly002","article-title":"Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice","volume":"77","author":"Daniele","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"15","key":"10.3233\/JND-180309_ref107","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/oxfordjournals.hmg.a018913","article-title":"Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway","volume":"9","author":"Blondeau","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.3233\/JND-180309_ref108","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.160255697","article-title":"Inaugural article: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate","volume":"97","author":"Taylor","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.3233\/JND-180309_ref109","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.M311071200","article-title":"Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells","volume":"279","author":"Tronchere","year":"2004","journal-title":"J Biol Chem"},{"issue":"Pt 8","key":"10.3233\/JND-180309_ref110","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1242\/jcs.118505","article-title":"Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo","volume":"126","author":"Amoasii","year":"2013","journal-title":"J Cell Sci"},{"issue":"7112","key":"10.3233\/JND-180309_ref111","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Di Paolo","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.3233\/JND-180309_ref112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.embor.7400919","article-title":"Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling","volume":"8","author":"Krauss","year":"2007","journal-title":"EMBO Rep"},{"issue":"3","key":"10.3233\/JND-180309_ref113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.200911020","article-title":"Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions","volume":"190","author":"Velichkova","year":"2010","journal-title":"J Cell Biol"},{"issue":"6","key":"10.3233\/JND-180309_ref114","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ajpath.2014.02.012","article-title":"Conditional knockout of pik3c3 causes a murine muscular dystrophy","volume":"184","author":"Reifler","year":"2014","journal-title":"Am J Pathol"},{"issue":"50","key":"10.3233\/JND-180309_ref115","doi-asserted-by":"crossref","first-page":"14432","DOI":"10.1073\/pnas.1604099113","article-title":"Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice","volume":"113","author":"Kutchukian","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.3233\/JND-180309_ref116","doi-asserted-by":"crossref","first-page":"e1002965","DOI":"10.1371\/journal.pgen.1002965","article-title":"Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice","volume":"8","author":"Amoasii","year":"2012","journal-title":"PLoS Genet"},{"issue":"5","key":"10.3233\/JND-180309_ref117","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Vanhaesebroeck","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.3233\/JND-180309_ref118","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J Clin Invest"},{"key":"10.3233\/JND-180309_ref119","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice","volume":"8","author":"Tasfaout","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JND-180309_ref120","doi-asserted-by":"crossref","unstructured":"Stein CA , Castanotto D . FDA-Approved Oligonucleotide Therapies in Mol Ther 2017;25(5):1069\u201375.","DOI":"10.1016\/j.ymthe.2017.03.023"},{"issue":"2","key":"10.3233\/JND-180309_ref121","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.3233\/JND-180309_ref122","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1093\/nar\/gku142","article-title":"Sequence motifs associated with hepatotoxicity of locked nucleic acid\u2013modified antisense oligonucleotides","volume":"42","author":"Burdick","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.3233\/JND-180309_ref123","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2013.02.359","article-title":"Acute kidney injury during therapy with an antisense oligonucleotide directed against PCSK9","volume":"62","author":"van Poelgeest","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.3233\/JND-180309_ref124","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.ajkd.2010.09.024","article-title":"Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY308 with reversible kidney injury in a patient with metastatic melanoma","volume":"57","author":"Herrington","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.3233\/JND-180309_ref125","doi-asserted-by":"crossref","unstructured":"Cowling BS , Prokic I , Tasfaout H , Rabai A , Humbert F , Rinaldi B , et al. Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation. J Clin Invest. 2017.","DOI":"10.1172\/JCI90542"},{"issue":"7","key":"10.3233\/JND-180309_ref126","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.nmd.2007.03.010","article-title":"Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy","volume":"17","author":"Pierson","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"17","key":"10.3233\/JND-180309_ref127","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J"},{"issue":"1","key":"10.3233\/JND-180309_ref128","first-page":"1","article-title":"Relationship between the proteasomal system and autophagy","volume":"4","author":"Lilienbaum","year":"2013","journal-title":"Int J Biochem Mol Biol"},{"key":"10.3233\/JND-180309_ref129","first-page":"5","article-title":"mTOR inhibitors in cancer therapy","author":"Xie","year":"2016","journal-title":"FRes"},{"issue":"6628","key":"10.3233\/JND-180309_ref130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.3233\/JND-180309_ref131","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ng1810","article-title":"A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects mus1524 cularity in sheep","volume":"38","author":"Clop","year":"2006","journal-title":"Nat Genet"},{"issue":"23","key":"10.3233\/JND-180309_ref132","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double muscling in cattle due to mutations in the myostatin gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/JND-180309_ref133","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.pgen.0030079","article-title":"A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs","volume":"3","author":"Mosher","year":"2007","journal-title":"PLoS Genet"},{"issue":"26","key":"10.3233\/JND-180309_ref134","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.3233\/JND-180309_ref135","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.0709144105","article-title":"Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors","volume":"105","author":"Haidet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6914","key":"10.3233\/JND-180309_ref136","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.3233\/JND-180309_ref137","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","article-title":"Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis","volume":"23","author":"Holzbaur","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.3233\/JND-180309_ref138","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.mt.6300182","article-title":"Antagonism of myostatin enhances muscle regeneration during sarcopenia","volume":"15","author":"Siriett","year":"2007","journal-title":"Mol Ther"},{"issue":"3","key":"10.3233\/JND-180309_ref139","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.3233\/JND-180309_ref140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.3233\/JND-180309_ref141","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08977190109029114","article-title":"GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding","volume":"18","author":"Thies","year":"2001","journal-title":"Growth Factors"},{"issue":"43","key":"10.3233\/JND-180309_ref142","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.1074\/jbc.M206379200","article-title":"The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum","volume":"277","author":"Hill","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"10.3233\/JND-180309_ref143","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/japplphysiol.00866.2009","article-title":"Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type","volume":"109","author":"Cadena","year":"2010","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.3233\/JND-180309_ref144","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.expneurol.2009.02.017","article-title":"A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis","volume":"217","author":"Morrison","year":"2009","journal-title":"Exp Neurol"},{"issue":"2","key":"10.3233\/JND-180309_ref145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajpath.2010.10.035","article-title":"Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice","volume":"178","author":"Lawlor","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.3233\/JND-180309_ref146","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat Commun"},{"issue":"Pt 20","key":"10.3233\/JND-180309_ref147","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1113\/jphysiol.2009.172544","article-title":"Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling","volume":"587","author":"Rodgers","year":"2009","journal-title":"J Physiol"},{"issue":"1","key":"10.3233\/JND-180309_ref148","doi-asserted-by":"crossref","first-page":"e1168553","DOI":"10.1080\/21659087.2016.1168553","article-title":"In vivo imaging of skeletal muscle in mice highlights muscle defects in a model of myotubular myopathy","volume":"5","author":"Mercier","year":"2016","journal-title":"Intravital"},{"key":"10.3233\/JND-180309_ref149","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0046-8177(84)80305-6","article-title":"X-linked recessive myotubular myopathy: II Muscle morphology and human myogenesis","volume":"15","author":"Ambler","year":"1984","journal-title":"Hum Pathol"},{"issue":"1","key":"10.3233\/JND-180309_ref150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-510X(94)90015-9","article-title":"Aberrant arrested in maturation neuromuscular junctions in centronuclear myopathy","volume":"124","author":"Fidzianska","year":"1994","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.3233\/JND-180309_ref151","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.3233\/JND-180309_ref152","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem Cell Therapies in Clinical Trials: Progress and Challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"17","key":"10.3233\/JND-180309_ref153","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3233\/JND-180309_ref154","first-page":"w13696","article-title":"Hematopoietic stem cell transplantation: A review and recommendations for follow-up care for the general practitioner","volume":"142","author":"Passweg","year":"2012","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.3233\/JND-180309_ref155","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/mt.2014.57","article-title":"Clarifying misconceptions about myoblast transplantation in myology","volume":"22","author":"Skuk","year":"2014","journal-title":"Mol Ther"},{"issue":"1","key":"10.3233\/JND-180309_ref156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.05.049","article-title":"Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles","volume":"134","author":"Cerletti","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.3233\/JND-180309_ref157","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nm0997-970","article-title":"The fate of individual myoblasts after transplantation into muscles of DMD patients","volume":"3","author":"Gussoni","year":"1997","journal-title":"Nat Med"},{"issue":"13","key":"10.3233\/JND-180309_ref158","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.3233\/JND-180309_ref159","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096368979300200203","article-title":"Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy","volume":"2","author":"Tremblay","year":"1993","journal-title":"Cell Transplant"},{"issue":"9","key":"10.3233\/JND-180309_ref160","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3727\/096368914X683494","article-title":"Syngeneic Myoblast Transplantation Improves Muscle Function in a Murine Model of X-Linked Myotubular Myopathy","volume":"24","author":"Lim","year":"2015","journal-title":"Cell Transplant"},{"issue":"9448","key":"10.3233\/JND-180309_ref161","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0140-6736(04)17443-6","article-title":"Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages","volume":"364","author":"Alessandri","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.3233\/JND-180309_ref162","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1534-5807(02)00254-X","article-title":"The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis","volume":"3","author":"Conboy","year":"2002","journal-title":"Dev Cell"},{"issue":"5650","key":"10.3233\/JND-180309_ref163","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.1087573","article-title":"Notch-mediated restoration of regenerative potential to aged muscle","volume":"302","author":"Conboy","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.3233\/JND-180309_ref164","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2004.10.021","article-title":"Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle","volume":"119","author":"Sherwood","year":"2004","journal-title":"Cell"},{"issue":"7","key":"10.3233\/JND-180309_ref165","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3727\/096368911X627480","article-title":"Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice","volume":"21","author":"Fakhfakh","year":"2012","journal-title":"Cell Transplant"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-180309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:33Z","timestamp":1777506813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-180309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":165,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jnd-180309","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]}}}